dengu
virus
import
arthropodborn
virus
term
morbid
mortal
world
sinc
dengu
vaccin
avail
human
use
set
investig
use
chloroquin
antivir
drug
dengu
chloroquin
amin
acidotrop
drug
known
affect
intracellular
exocyt
pathway
increas
endosom
ph
use
vitro
treatment
vero
cell
infect
dengu
viru
type
realtim
rtpcr
plaqu
assay
use
quantifi
load
infect
vero
cell
chloroquin
treatment
result
show
dose
gml
chloroquin
toxic
cell
induc
statist
signific
inhibit
viru
product
infect
vero
cell
compar
untreat
cell
cell
chloroquin
induc
statist
signific
differ
viral
replic
compar
untreat
cell
show
viru
use
unlik
pathway
penetr
cell
result
also
confirm
plaqu
assay
pfu
data
suggest
inhibit
viru
infect
induc
chloroquin
due
interfer
acid
vesicl
mammalian
cell
dengu
virus
denv
singlestrand
positivesens
rna
virus
belong
genu
flaviviru
famili
flavivirida
consist
four
serotyp
transmit
human
higher
primat
mosquito
genu
aed
denv
caus
import
arthropodborn
viral
diseas
world
character
wide
spectrum
clinic
manifest
rang
flulik
diseas
dengu
fever
lifethreaten
diseas
known
dengu
hemorrhag
feverdengu
shock
syndrom
dhfdss
avail
way
control
dengu
vector
control
sinc
neither
vaccin
human
use
antivir
drug
inhibit
viru
replic
littl
known
site
flaviviru
assembl
detail
matur
decreas
endosom
ph
necessari
flaviviru
envelop
fusion
endosom
membran
lead
releas
viral
capsid
cytosol
initi
viru
replic
weak
base
chloroquin
clq
accumul
acid
vesicl
rais
ph
therein
prevent
low
phinduc
fusion
viral
envelop
cell
endosom
membran
clq
potenti
abl
block
entri
certain
virus
cytosol
present
studi
examin
effect
clq
replic
vero
mammalian
mosquito
cell
order
defin
whether
clq
could
use
reduc
viral
yield
vero
cell
continu
cell
lineag
origin
kidney
african
green
monkey
grown
cultur
medium
invitrogen
new
york
usa
supplement
fetal
bovin
serum
fb
lglutamin
mm
penicillin
g
uml
streptomycin
gml
triptos
scientif
world
journal
phosphat
vero
cell
maintain
c
co
aed
albopictu
cell
line
cultur
medium
supplement
fb
lglutamin
triptos
phosphat
penicillin
g
uml
streptomycin
gml
c
absenc
co
stock
new
guinea
c
strain
recov
brain
newborn
swiss
mice
use
studi
viral
stock
prepar
inocul
cell
contain
cm
cultur
flask
viru
dilut
ml
fb
h
ml
supplement
fb
ad
cell
cultur
day
cell
cultur
supernat
harvest
centrifug
xg
min
remov
cell
debri
supernat
contain
viru
adjust
fb
aliquot
store
c
viru
stock
cell
cultur
supernat
use
present
studi
free
lipopolysaccharid
mycoplasma
use
studi
show
best
titrat
preliminari
experi
assess
antivir
effect
chloroquin
vero
cell
viru
product
titrat
plaqu
assay
use
vero
cell
vero
cell
seed
cellswel
plate
medium
fb
h
c
medium
remov
decim
serial
dilut
viru
stock
supernat
cell
treat
clq
prepar
medium
fb
ad
mlwell
cell
incub
h
c
subsequ
medium
contain
fb
carboxymethylcellulos
mlwell
overlay
ad
plate
incub
c
day
overlay
remov
day
seven
cell
fix
solut
formaldehyd
pb
hour
room
temperatur
formaldehyd
solut
remov
cell
wash
twice
pb
stain
min
crystal
violet
solut
ethanol
plaqu
cell
lysi
count
viru
concentr
express
plaqu
form
unit
pfu
per
millilit
cytotox
induc
clq
assay
vero
cell
determin
ideal
concentr
experi
vero
cell
seed
cellswel
plate
incub
period
approxim
hour
cultur
medium
replac
medium
contain
fb
differ
concentr
clq
sigmaaldrich
usa
incub
period
hour
drug
cell
remov
trypsin
viabil
vero
cell
confirm
trypan
blue
exclus
method
invitrogen
new
york
usa
monolay
vero
cell
seed
onto
plate
infect
multipl
infect
moi
h
postinfect
pi
inoculum
remov
vero
cell
incub
presenc
differ
concentr
clq
gml
defin
time
interv
differ
experi
concomitantli
h
infect
ii
concomitantli
h
infect
interv
day
iii
concomitantli
hour
infect
interv
day
replic
mock
control
gml
infect
cell
supernat
collect
hour
postinfect
clear
centrifug
store
aliquot
c
use
realtim
pcr
plaqu
assay
experi
carri
duplic
result
shown
mean
valu
obtain
three
individu
experi
viral
rna
extract
viral
rna
extract
l
supernat
sampl
use
qiaamp
viral
rna
kit
qiagen
usa
accord
manufactur
direct
chain
reaction
qrtpcr
assay
realtim
qrtpcr
determin
number
rna
copi
present
supernat
carri
describ
previous
briefli
construct
standard
curv
number
particl
produc
infect
cell
measur
number
rna
copi
quantit
qrtpcr
serial
dilut
infect
cell
supernat
qrtpcr
contain
l
sybr
green
master
mix
reagent
appli
biosystem
l
rnase
inhibitor
l
multiscrib
u
l
l
primer
nm
specif
design
anneal
untransl
region
utr
l
depc
water
l
rna
final
volum
l
amplif
protocol
consist
follow
step
c
min
c
min
follow
cycl
c
second
final
c
min
protocol
use
quantifi
rna
copi
present
supernat
clqtreat
untreat
vero
cell
infect
collect
defin
postinfect
interv
describ
analysi
statist
analysi
use
assess
differ
viral
yield
timedefin
interv
produc
infect
cell
contact
clq
compar
control
cell
without
drug
data
enter
graphpad
prism
softwar
version
graphpad
softwar
inc
eua
submit
oneway
anova
nonparametr
test
analysi
follow
bonferroni
test
analys
valu
consid
statist
signific
cell
clq
highli
cytotox
vero
cell
treat
concentr
equal
higher
gml
signific
cytotox
observ
cell
treat
concentr
equal
lower
gml
figur
base
scientif
world
journal
chloroquin
gml
figur
effect
clq
cytotox
cell
concentr
equal
higher
gml
clq
highli
cytotox
cell
concentr
equal
lower
gml
clq
induc
signific
cytotox
concentr
equal
higher
gml
clq
highli
cytotox
vero
cell
concentr
equal
lower
gml
clq
induc
signific
cytotox
data
clq
use
concentr
equal
lower
gml
use
experi
determin
whether
clq
would
inhibit
replic
monolay
vero
cell
infect
incub
fb
medium
contain
differ
concentr
drug
viru
product
quantifi
qrtpcr
plaqu
assay
clq
effect
replic
cell
figur
show
dosedepend
inhibit
viru
replic
vero
cell
analyz
qrtpcr
figur
viral
replic
vero
cell
significantli
reduc
addit
gml
clq
h
infect
compar
untreat
cell
inhibit
maintain
h
infect
figur
result
obtain
analysi
carri
plaqu
assay
excel
correl
qrtpcr
data
shown
viral
inhibit
effect
induc
clq
h
may
relat
consumpt
drug
analyz
antivir
effect
clq
vero
cell
treat
hour
postinfect
viral
rna
copi
number
hour
postinfect
viral
rna
copi
number
drug
hour
infect
interv
infect
qrtpcr
show
signific
reduct
viral
yield
compar
untreat
cell
day
infect
figur
analysi
plaqu
assay
agreement
qrtpcr
data
shown
hour
postinfect
viral
rna
copi
number
viral
replic
veroinfect
cell
impair
addit
clq
hour
infect
interv
infect
approach
plaqu
assay
qrtpcr
show
statist
signific
reduct
viral
yield
similar
obtain
cell
expos
clq
interv
report
data
show
clq
effect
antivir
agent
cell
cultur
condit
inhibitori
effect
observ
drug
ad
h
initi
infect
probabl
due
increas
endosom
ph
thu
subvert
ongo
fusion
event
viru
envelop
endosom
membran
result
suggest
clq
could
potenti
therapeut
use
dengu
viru
even
virus
penetr
cell
endocytosi
sens
studi
shown
clq
inhibit
sar
coronaviru
sarscov
replic
vitro
addit
di
trani
et
al
test
antivir
effect
clq
vitro
select
human
avian
virus
belong
differ
subtyp
display
differ
ph
requir
author
found
clq
inhibitori
effect
virus
drug
ad
time
infect
effect
lost
postinfect
final
eng
et
al
report
clq
abl
inhibit
influenza
viru
replic
vitro
hour
postinfect
viral
rna
copi
number
clq
safe
drug
half
centuri
use
treatment
malaria
therefor
implement
protocol
use
dengu
treatment
would
problem
sinc
correl
high
viral
load
develop
dhfdss
use
clq
treat
dengu
viru
infect
soon
patient
present
dengu
symptom
could
prevent
develop
sever
form
diseas
due
reduct
dengu
viremia
furthermor
due
interfer
tnfcytotox
clq
would
probabl
reduc
inflammatori
symptom
high
fever
backach
associ
dengu
inhibitori
effect
clq
viru
replic
mammalian
cell
alreadi
studi
virus
drug
use
control
infect
coronaviru
sarscv
etiolog
agent
sever
acut
respiratori
syndrom
sar
nonhuman
primat
cell
vero
also
use
inhibit
replic
human
immunodefici
viru
lineag
monocyt
lymphocyt
lineag
cell
furthermor
clq
use
inhibit
kunjin
viru
replic
cell
nonhuman
primat
vero
dengu
virus
replic
well
cell
mosquito
line
present
use
sensit
assay
viru
isol
patient
vero
also
permiss
cell
line
present
studi
observ
experi
carri
cell
infect
treat
clq
reduc
viral
load
coomb
et
al
observ
also
clq
reduc
viral
load
experi
carri
sindbi
viru
cell
mosquito
aed
albopictu
hernandez
et
al
obtain
similar
result
use
clq
inhibit
replic
sindbi
viru
two
explan
possibl
find
clq
block
endosom
acidif
cell
mosquito
aed
albopictu
ii
clq
block
endosom
acidif
infect
mosquito
cell
sindbi
viru
fact
suggest
replic
use
experi
aed
albopictu
cell
occur
possibl
pathway
intracytoplasm
penetr
endosom
one
block
clq
taken
togeth
data
obtain
studi
result
suggest
clq
interfer
viru
replic
vero
cell
cultur
cell
thu
chloroquin
consid
safe
effect
drug
use
treatment
mani
diseas
includ
malaria
therapeut
use
promis
shown
studi
drug
signific
antivir
effect
replic
viru
cell
cultur
